PROTEASE FROM BACILLUS SUBTILIS
Protease from Bacillus subtilis is a bacterially derived enzyme preparation used in food processing to hydrolyze proteins. It is affirmed as GRAS by the US FDA under 21 CFR 184.1150, with technical functions including enzyme activity, flavor enhancement, processing aid, and stabilizing roles in formulations.
What It Is
Protease from Bacillus subtilis is a food enzyme preparation derived from the culture filtrate of a pure culture fermentation of a nonpathogenic and nontoxigenic strain of the bacterium Bacillus subtilis. This enzyme preparation contains proteolytic enzymes, including subtilisin and neutral proteinase, which catalyze the hydrolysis of peptide bonds in proteins. Proteases are widely recognized biochemical catalysts that break down proteins into smaller peptides or amino acids by targeting specific peptide linkages. In the context of food technology, protease from Bacillus subtilis serves multiple technical functions related to protein hydrolysis, flavor enhancement, and processing efficiency. The designation of this protease under the regulatory reference 21 CFR 184.1150 indicates that it has been reviewed by the United States Food and Drug Administration (FDA) and affirmed as generally recognized as safe (GRAS) for use in foods under the conditions prescribed in that regulation. The protease preparation may be listed under various other names in ingredient databases or technical literature, including Bacillus subtilis proteinase or simply protease, reflecting its protein hydrolyzing activity and bacterial origin.
How It Is Made
The production of protease from Bacillus subtilis involves industrial fermentation of a selected strain of Bacillus subtilis that is nonpathogenic and nontoxigenic. In this process, the microorganism is cultured under controlled conditions suitable for high-level enzyme expression. After sufficient growth and enzyme secretion into the culture medium, the liquid fermentation broth is typically separated from bacterial cells and other solids by filtration or centrifugation. The culture filtrate, which contains the protease enzymes of interest, is then subjected to further purification steps to isolate the active enzyme fraction. These steps may include filtration, ultrafiltration, concentration, and other standard downstream processing techniques appropriate for enzyme preparations. In some cases, additional formulation steps such as stabilization with carrier substances or drying to a powder form may be applied to create a stable product for use in food manufacturing. The specific manufacturing steps and conditions are designed to meet food-grade quality and purity specifications, such as those described in compendia for enzyme preparations. A key objective in the production process is to ensure that the final enzyme preparation meets defined identity and purity standards and is free from undesirable contaminants. Because proteases are proteins that can lose activity if denatured, production and processing conditions are optimized to preserve enzyme function. Enzyme formulation may take place under controlled temperatures and pH ranges to maintain activity and stability.
Why It Is Used In Food
Protease from Bacillus subtilis is used in food processing because of its ability to catalyze the breakdown of proteins into peptides and free amino acids. In food formulation and processing, controlled proteolysis achieved by adding protease can improve texture, enhance flavors, and modify functional properties of proteins. Hydrolysis of proteins can lead to increased solubility, reduced viscosity, or changes in gel formation, which can be beneficial in products such as protein hydrolysates, meat analogs, and fermented foods. Proteases are also applied as processing aids, where they act during manufacturing but are not intended to remain active in the final product at significant levels. In certain applications, proteases contribute to the development of specific taste profiles by releasing amino acids and peptides that influence umami or savory notes. The use of proteases thus supports formulation objectives such as improving digestibility, optimizing texture, and enhancing the overall eating experience. Their inclusion in food production processes is guided by both their technological functionality and regulatory status, ensuring that they achieve the desired effects without compromising product safety or compliance with food laws.
Adi Example Calculation
Because protease from Bacillus subtilis is affirmed for use under conditions of good manufacturing practice without a numeric acceptable daily intake (ADI), there is no specific numeric ADI to apply in illustrative intake calculations. Under such regulatory frameworks, the focus is on ensuring enzyme use levels are appropriate and justified for their technological function rather than consuming a specified amount. Illustrative intake calculations for substances with defined numeric ADIs typically involve multiplying the ADI value by a hypothetical body weight to estimate a daily intake threshold. In the case of enzyme preparations where no numeric ADI has been specified, this type of calculation is not applicable.
Safety And Health Research
Protease preparations derived from Bacillus subtilis have been evaluated primarily for their technological safety and suitability for use in food processing. The United States FDA’s affirmation of GRAS status for bacterially derived protease enzyme preparations reflects a determination that the enzyme preparation can be safely used in food when produced from nonpathogenic and nontoxigenic strains and manufactured under appropriate quality controls. Safety considerations for enzymes typically include the absence of toxic contaminants in the preparation and assurance that the production organism does not produce harmful metabolites. Scientific evaluations often incorporate assessments of the production strain’s safety profile, compositional analysis of the enzyme preparation, and an absence of evidence for adverse effects when the enzyme is used under intended conditions. While specific toxicological studies addressing systemic physiological effects in humans may be limited, regulators focus on manufacturing quality, purity specifications, and historical use as bases for safety evaluations. Investigations of similar enzyme preparations from Bacillus subtilis and related strains have reported no indications of significant toxicity in relevant test systems when enzymes are prepared and used according to defined specifications. Research literature on enzyme preparations further supports that properly characterized protease preparations do not raise safety concerns when used within defined technological contexts.
Regulatory Status Worldwide
In the United States, protease from Bacillus subtilis is affirmed as generally recognized as safe (GRAS) when used in food under conditions prescribed in 21 CFR 184.1150, which describes bacterially derived protease enzyme preparations. This regulatory listing reflects a review by the FDA that considers the safety of the enzyme preparation and its use in food under good manufacturing practice conditions. The regulation specifies that the preparation is derived from nonpathogenic and nontoxigenic strains of Bacillus subtilis, and the ingredient meets general and additional requirements for enzyme preparations. Under this status, the enzyme is used in accordance with current good manufacturing practice and at levels needed to achieve its intended technical effects. In other regulatory frameworks, enzymes such as proteases may be subject to separate authorization processes; for example, under the European Union food enzyme regulation, all enzymes intended for use in foods must undergo safety evaluation by the European Food Safety Authority (EFSA) and be approved for inclusion in a Union list of authorized food enzymes before they can be marketed. As of now, there is no comprehensive EU Union list that includes all food enzymes. Joint FAO/WHO expert committees such as JECFA have evaluated enzyme preparations from Bacillus subtilis and related organisms in the past, often establishing that their use is limited by good manufacturing practice rather than a numeric acceptable daily intake. Regulatory approaches vary internationally, and the use of enzyme preparations in food is subject to compliance with applicable national or regional food laws.
Taste And Functional Properties
Protease enzymes from Bacillus subtilis typically exhibit broad protein-hydrolyzing activity, with catalytic capabilities that allow them to break peptide bonds in a range of substrate proteins. While the specific taste impact of proteolysis depends on the food matrix and extent of hydrolysis, shorter peptides and amino acids released by protease action may contribute to savory characteristics and enhance flavor perception in certain products. Functional properties of proteases include the ability to modify protein solubility, influence gelation behavior, and adjust texture in protein-rich foods. The activity of these enzymes can be sensitive to factors such as pH and temperature, and protease preparations are often formulated to retain activity within the processing conditions typical of the target application. The stability of protease activity across a range of pH values and moderate heat can be an important consideration in process design, as enzyme function may diminish outside its optimal operating conditions. Because these enzymes catalyze hydrolysis reactions efficiently, they can act quickly at low addition levels when used as processing aids. Protease preparations are not intended to alter taste in all food systems, and the extent to which proteolytic products contribute to sensory attributes is highly context specific.
Acceptable Daily Intake Explained
Acceptable daily intake (ADI) is an estimate of the amount of a substance in food or drinking water that can be ingested daily over a lifetime without appreciable health risk. For many enzyme preparations such as protease from Bacillus subtilis that are affirmed as GRAS or otherwise approved under food regulations, a numeric ADI is not established because the safety assessment concludes that there is no hazard at levels of exposure consistent with good manufacturing practice. In such cases, regulatory frameworks may state that use is governed by conditions of good manufacturing practice rather than a specified numeric intake limit. This reflects that the enzyme preparation is used at levels necessary to achieve technological effects and that residues in the final food are minimal and considered safe based on the available evidence. ADI considerations emphasize that safety evaluations are grounded in scientific data and established regulatory criteria.
Comparison With Similar Additives
Protease from Bacillus subtilis can be compared with other proteolytic enzyme additives such as papain and bromelain. Papain, derived from papaya latex, is a plant-based protease that hydrolyzes proteins and is used in meat tenderization and other food applications. Bromelain, sourced from pineapple stems and fruit, similarly hydrolyzes proteins and finds use in processed meats and as a meat tenderizer. While all three enzymes serve protein hydrolysis functions, differences exist in their biological source and optimal activity conditions; microbial proteases such as those from Bacillus subtilis are typically tailored for industrial fermentation and can be produced in large quantities with consistent activity. Plant-derived proteases like papain and bromelain may have different substrate specificities and activity profiles based on pH and temperature. Another comparison can be made with fungal proteases used in certain food and fermentation applications. Fungal proteases, while also effective at protein hydrolysis, may have distinct regulatory statuses and functional properties that influence their use in specific food systems. Across these examples, formulation choices are guided by the desired technological effect, regulatory acceptance, and practical considerations such as stability and activity under processing conditions.
Common Food Applications Narrative
Protease from Bacillus subtilis finds application across a range of food production processes where controlled protein hydrolysis can improve product characteristics. In the manufacture of fermented foods, protease activity can support the breakdown of complex proteins into peptides that contribute to desired textures and flavors. In protein hydrolysate production, the enzyme assists in creating peptide mixtures that serve as functional ingredients or specialized nutritional components. Proteases are also used in meat processing, where they can tenderize proteins and improve texture in processed meat products. The ability of proteases to modify protein structure finds utility in baked goods and grain-based products, where controlled hydrolysis can influence dough properties and final product quality. Additionally, protease may be used in the production of savory flavor enhancers, where protein breakdown products enhance umami taste profiles. In broader processing contexts, these enzymes can support formulation goals such as reducing viscosity in liquid proteins or improving solubility for certain ingredient systems. Across these applications, the implementation of protease is guided by its technological functionality and compliance with food processing standards defined by regulatory authorities.
Safety & Regulations
FDA
- Approved: True
- Regulation: 21 CFR 184.1150
EFSA
- Notes: EFSA approval for specific uses not established because EU list of authorized food enzymes is pending
JECFA
- Notes: JECFA evaluation available for related mixed enzyme preparations but not a specific numeric ADI
Comments
Please login to leave a comment.
No comments yet. Be the first to share!